Health
FDA approves clinical trials to test the safety of cancer-detection technology – News-Medical.Net
The U.S. Food and Drug Administration has approved human clinical trials to test the safety of cancer-detection technology developed at Case Western Reserve University:…
The U.S. Food and Drug Administration has approved human clinical trials to test the safety of cancer-detection technology developed at Case Western Reserve University: a tumor-targeting contrast agent that accurately detects aggressive prostate cancer in a magnetic resonance imaging (MRI) scan.
The molecular-targeted imaging agent is licensed to Molecular Theranostics LLC, a Cleveland based startup company, and its partners U.S. Motek LLC and Jiangsu Motek Pharmaceuticals Ltd. of China.
The agent…
-
Noosa News15 hours agoQueensland weather forecast sees sunny weather for last week of winter
-
Noosa News16 hours agoForum responds to urgent homelessness issues in Nambour
-
General15 hours agoEnergy provider ENGIE to ‘correct’ electricity bills for thousands of South Australian customers
-
Business14 hours agoDoes Macquarie rate BHP shares a buy after its FY25 results?